Trials / Active Not Recruiting
Active Not RecruitingNCT07289919
Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils
Exploring Sustainable Alternatives to Marine Oils: A Clinical Trial on the Efficacy of Echium and Ahiflower Oils for Omega-3 Supplementation.
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This randomized, single-blind, crossover clinical trial aims to evaluate Echium oil and Ahiflower® oil as sustainable, plant-based alternatives to marine oils for omega-3 supplementation. Although fish oil is the primary dietary source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), its use as a dietary supplementation presents several drawbacks, including high cost, potential contamination, limited global supply, and sustainability concerns. Echium and Ahiflower oils are naturally rich in stearidonic acid (SDA), a metabolic intermediate that bypasses the rate-limiting Δ6-desaturase step in the omega-3 pathway, potentially enhancing the conversion to EPA. Fifteen participants will undergo three 8-week intervention phases-Echium oil (15 g/day), Ahiflower oil (15 g/day), or EPA capsules (2.34 g/day)-separated by four-week washout periods. Blood samples will be collected before and after each phase to measure fatty acid profiles in plasma, plasma fractions, and erythrocytes using GC-MS. Anthropometric and biochemical parameters will also be assessed. The study seeks to determine whether SDA-rich plant oils can effectively increase EPA levels in humans and potentially reduce the reliance on marine oils for cardiovascular health benefits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Echium oil | Participants consume 15 g/day of Echium oil, incorporated into meals, during one 8-week phase. |
| DIETARY_SUPPLEMENT | Ahiflower oil | Participants consume 15 g/day of Ahiflower® oil, incorporated into meals, during one 8-week phase. |
| DIETARY_SUPPLEMENT | EPA capsules | Participants consume three EPA capsules daily (totaling 2.34 g/day), taken with meals, during one 8-week phase. |
Timeline
- Start date
- 2025-05-26
- Primary completion
- 2026-03-05
- Completion
- 2026-12-31
- First posted
- 2025-12-17
- Last updated
- 2025-12-17
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT07289919. Inclusion in this directory is not an endorsement.